Specific compatibility considerations include confirmation of absence of reducing agents for disulphide-containing peptides, BSA carrier supplementation for recombinant proteins, and acetic acid acidification for hydrophobic peptides requiring low pH solubilisation
By Sandra C
Systemic inflammation that has no single injury source, the kind that shows up as widespread musculoskeletal pain, persistent fatigue, and poor recovery from training, is typically where BPC-157 works best as part of a stack rather than in isolation
A peptide that has changed color in its powder form (from white to yellow or brown) is likely degraded
The Promises and Pitfalls of BPC-157 BPC-157, or Body Protection Compound-157, is a peptide derived from a protein found in the stomach
so far, this is going very well three weeks in to the first dose of appetite